NCT06232044 2026-03-25Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple MyelomaAlliance for Clinical Trials in OncologyPhase 1/2 Recruiting88 enrolled